VisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug

Press Release, August 22, 2019

more No Comments August 22 2019

VisionGate Announces the Results and Presentation of Important New Research at the 2018 IASLC World Conference on Lung Cancer (WCLC), Toronto, Canada.

Press Release, September 24, 2018

more September 28 2018

VisionGate Hires Renowned Chief Medical Officer Dr. Javier Zulueta

more No Comments June 2 2016

VisionGate Receives Strategic Investment from Trinnovate Ventures

more No Comments March 16 2016

Biotech Showcase 2016 Interview: Diagnostics company VisionGate migrates into diagnostics

more No Comments February 24 2016

Phoenix firefighters get free lung-cancer testing

more No Comments December 4 2015

Significant Lung Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology

more No Comments July 9 2015

VisionGate Receives Backing From Dignity Health in Arizona

more No Comments February 3 2015

VisionGate Adds 3 Prominent Directors

more No Comments June 20 2014

Lung cancer test shows high senstitivity, specificity, and early stage detection

more No Comments May 23 2014

Copyright 2020 - VisionGate, Inc.